A

MuSK inhibition

Espacenet Family 63966028

Abstract

Novel methods for treating condition, disorder and/or symptom which is alleviated by the inhibition of neuromuscular transmission in a subject are provided herein. The invention also provides binding agents for use in treating the same.

Inventors 4

  1. Silvère, Maria van der Maarel
  2. Johannes, Justus Gerard Maria Verschuuren
  3. Martina, Gerardina Maria Huijbers
  4. Jakob, Jan Plomp

Inventors are linked to an Aachen author when surname and first name match exactly one author.

Applicants

  • ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) GBS Leiden

Cited papers 6 in the database

Non-patent literature as cited (7)
  • - KONECZNY INGA ET AL: "IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients", JOURNAL OF AUTOIMMUNITY, LONDON, GB, vol. 77, 10 December 2016 (2016-12-10), pages 104 - 115, XP029897113, ISSN: 0896-8411, DOI: 10.1016/J.JAUT.2016.11.005 * the whole document *
  • - JAN J.G.M. VERSCHUUREN ET AL: "Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies : MuSK MG passive transfer", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 1413, no. 1, 21 January 2018 (2018-01-21), US, pages 111 - 118, XP055587218, ISSN: 0077-8923, DOI: 10.1111/nyas.13543 * the whole document *
  • - MAARTJE G. HUIJBERS ET AL: "IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders : IgG4-mediated autoimmune diseases", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 1413, no. 1, 28 January 2018 (2018-01-28), US, pages 92 - 103, XP055587211, ISSN: 0077-8923, DOI: 10.1111/nyas.13561
  • - MORI SHUUICHI ET AL: "Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis", JOURNAL OF NEUROIMMUNOLOGY, vol. 244, no. 1, 1 January 2012 (2012-01-01), pages 1 - 7, XP028903355, ISSN: 0165-5728, DOI: 10.1016/J.JNEUROIM.2011.12.005
  • - SARAH CANTOR ET AL: "Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody", ELIFE, vol. 7, 20 February 2018 (2018-02-20), XP055587207, DOI: 10.7554/eLife.34375
  • - MASAHARU TAKAMORI: "Structure and function of neuromuscular junction, centered on muscle-specific tyrosine kinase and related proteins", CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, vol. 7, no. 3, 1 August 2016 (2016-08-01), pages 215 - 225, XP055587248, ISSN: 1759-1961, DOI: 10.1111/cen3.12314
  • - MAARTJE G. HUIJBERS ET AL: "MuSK myasthenia gravis monoclonal antibodies : Valency dictates pathogenicity", NEUROLOGY - NEUROIMMUNOLOGY NEUROINFLAMMATION, vol. 6, no. 3, 21 February 2019 (2019-02-21), pages e547, XP055585991, DOI: 10.1212/NXI.0000000000000547